A biopharmaceutical company based in the U.S., Gilead Sciences took a decision to invest in Turkey’s Pharmactive to produce HIV and Hepatitis drugs in Turkey. According to a statement released by Gilead Sciences, the investment is expected to reach TRY 350 million, including the machinery and equipment for local manufacturing, capital increase and transfer of know-how as part of the...
Global Ports Holding Plc (GPH) has signed an agreement with QTerminals for the acquisition of Port Akdeniz in the Antalya province of Turkey. According to a statement released by GPH on October 21, the total value of the transaction is USD 140 million. Port Akdeniz is the largest port in Global Ports Holding's portfolio and the company has the operating rights of the port until...
